WMT

127.53

+2.16%↑

COST

999.79

+1.27%↑

TGT

127.27

+2.79%↑

KR

68.16

+0.58%↑

STZ

161.86

-1.25%↓

WMT

127.53

+2.16%↑

COST

999.79

+1.27%↑

TGT

127.27

+2.79%↑

KR

68.16

+0.58%↑

STZ

161.86

-1.25%↓

WMT

127.53

+2.16%↑

COST

999.79

+1.27%↑

TGT

127.27

+2.79%↑

KR

68.16

+0.58%↑

STZ

161.86

-1.25%↓

WMT

127.53

+2.16%↑

COST

999.79

+1.27%↑

TGT

127.27

+2.79%↑

KR

68.16

+0.58%↑

STZ

161.86

-1.25%↓

WMT

127.53

+2.16%↑

COST

999.79

+1.27%↑

TGT

127.27

+2.79%↑

KR

68.16

+0.58%↑

STZ

161.86

-1.25%↓

Search

Afya Ltd (Class A)

Cerrado

SectorConsumo defensivo

15.73 0.06

Resumen

Variación precio

24h

Actual

Mínimo

15.14

Máximo

15.91

Métricas clave

By Trading Economics

Ingresos

-5M

176M

Ventas

-1.6M

927M

P/B

Media del Sector

9.549

28.443

Rentabilidad por dividendo

4.19

Margen de beneficios

18.945

EBITDA

-120M

277M

Recomendaciones

By TipRanks

Recomendaciones

Vender

Estimación a 12 Meses

+7.55% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

4.19%

3.58%

Próximas Ganancias

7 may 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

135M

1.4B

Apertura anterior

15.67

Cierre anterior

15.73

Noticias sobre sentimiento de mercado

By Acuity

100%

0%

128 / 131 Clasificación en Consumer defensive

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Afya Ltd (Class A) Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

17 abr 2026, 20:26 UTC

Adquisiciones, fusiones, absorciones

UCB to Buy Neurona Therapeutics for Up to $1.15 Billion

17 abr 2026, 18:15 UTC

Noticias de Eventos Importantes

Fed's Waller: Prolonged Iran Conflict Could Block Path to Rate Cuts

17 abr 2026, 16:49 UTC

Noticias de Eventos Importantes

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

17 abr 2026, 16:49 UTC

Noticias de Eventos Importantes

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI Data Due as Focus Remains on Middle East

17 abr 2026, 22:58 UTC

Ganancias

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17 abr 2026, 21:32 UTC

Charlas de Mercado

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17 abr 2026, 21:22 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

17 abr 2026, 21:22 UTC

Charlas de Mercado

Moody's Downgrades Belgium to A1 -- Market Talk

17 abr 2026, 20:52 UTC

Ganancias

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17 abr 2026, 20:50 UTC

Charlas de Mercado
Ganancias
Adquisiciones, fusiones, absorciones

Tech, Media & Telecom Roundup: Market Talk

17 abr 2026, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

17 abr 2026, 20:29 UTC

Ganancias

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

17 abr 2026, 20:11 UTC

Adquisiciones, fusiones, absorciones

UCB to Buy Neurona Therapeutics for Up to $1.15B

17 abr 2026, 19:34 UTC

Charlas de Mercado
Ganancias
Adquisiciones, fusiones, absorciones

Global Equities Roundup: Market Talk

17 abr 2026, 19:34 UTC

Charlas de Mercado
Ganancias
Adquisiciones, fusiones, absorciones

Analysts See Netflix's Deal Commentary as Notable -- Market Talk

17 abr 2026, 19:31 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Oil Futures Fall on Reopening of Strait of Hormuz -- Market Talk

17 abr 2026, 19:26 UTC

Charlas de Mercado

U.S. Natural Gas Futures Edge Up -- Market Talk

17 abr 2026, 19:21 UTC

Charlas de Mercado

Albemarle's Outperformance Belies Longer-Term Risks -- Market Talk

17 abr 2026, 19:15 UTC

Charlas de Mercado

Danaher Seen Rebounding in 2H After Tools-Sector Weakness -- Market Talk

17 abr 2026, 19:07 UTC

Charlas de Mercado

Danaher Faces Tough Comparative but Long‑Term Story Intact -- Market Talk

17 abr 2026, 18:57 UTC

Noticias de Eventos Importantes

U.S. Stocks Surge on Hope Iran War Nearing End. Foreign Leaders Have a More Sober View. -- Barrons.com

17 abr 2026, 18:53 UTC

Adquisiciones, fusiones, absorciones

UCB Expects 2026 Adjusted Ebitda Growth in High Single-Digit to Mid-Teens Percentage Range at Constant Exchange Rates

17 abr 2026, 18:53 UTC

Adquisiciones, fusiones, absorciones

UCB 2026 Rev Guidance Unchanged

17 abr 2026, 18:52 UTC

Adquisiciones, fusiones, absorciones

UCB: Neurona Deal to Include $650M Upfront and Up to $500M in Potential Future Milestones

17 abr 2026, 18:52 UTC

Adquisiciones, fusiones, absorciones

UCB to Acquire Neurona Therapeutics for Up to $1.15B Including Potential Milestones

17 abr 2026, 18:14 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Precious Metals Close Higher as Stronger Demand Eyed -- Market Talk

17 abr 2026, 18:00 UTC

Noticias de Eventos Importantes

Fed's Waller: Quick Resolution in Middle East Could Allow Cuts Later This Year

17 abr 2026, 18:00 UTC

Noticias de Eventos Importantes

Fed's Waller: Job Losses May Not Signal Recession Amid Demographic Changes

17 abr 2026, 17:31 UTC

Charlas de Mercado
Noticias de Eventos Importantes

U.S. Oil Rig Count Down By 1 at 410 -- Market Talk

17 abr 2026, 17:26 UTC

Charlas de Mercado
Ganancias

Netflix's Ability to Grow Engagement Seen as Up in the Air -- Market Talk

Comparación entre iguales

Cambio de precio

Afya Ltd (Class A) previsión

Precio Objetivo

By TipRanks

7.55% repunte

Estimación a 12 Meses

Media 16.67 USD  7.55%

Máximo 17 USD

Mínimo 16 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Afya Ltd (Class A) Dist en los últimos 3 meses.

Consenso

By TipRanks

Vender

3 ratings

0

Comprar

2

Mantener

1

Vender

Puntuación técnica

By Trading Central

18.968 / 19.56Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Strong Bullish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Afya Ltd (Class A)

Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
help-icon Live chat